ALSF and RUNX1 Research Program have partnered to raise awareness and accelerate research around familial RUNX1 disorders through the RUNX1 Early Career Investigator Grant and the Research Accelerating RUNX1 Exploration Grant

The Research Accelerating RUNX1 Exploration Grant: Up to $250,000 over 2 years
The Research Accelerating RUNX1 Exploration (RARE) Grant is a two-year award designed to fund research that will lead to the development of therapies for patients with RUNX1-FPD that will either intercept the transition from a precancer state (clonal hematopoiesis) to MDS/AML or prevention of cancer (before clonal hematopoiesis).

The RUNX1 Early Career Investigator Grant: Up to $180,000 over three years
The purpose of the RUNX1 Early Career Investigator Grant is to promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding into where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention. The Program is viewed as a long-term endeavor of collaboration and data sharing. We are especially interested in innovative and cross-disciplinary approaches to developing effective therapies.

The Research Accelerating RUNX1 Exploration Grant is currently being offered. To apply, please visit the Applicant page.